Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Aug 14, 2012 (14 years ago)

Prometh VC with Codeine Cough Syrup

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Impurities/Degradation Products: Recalled lots do not meet room temperature stability specification for unknown degradant.

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Prometh VC with Codeine Cough Syrup, CV, Each 5mL contains: Codeine phosphate 10mg; promethazine hydrochloride 6.25mg; phenylephrine hydrochloride 5mg, One Pint Bottles (473mL), Rx Only, Manufactured by: Actavis Mid Atlantic LLC., 1877 Kawaii Road, Lincolnton, NC 28092 USA, NDC 0472-1629-16

Affected NDC 0472-1629-16

Compare with the code on your package — it is the most precise check available.

Drug: Phenylephrine

Recalling firm
Actavis Mid Atlantic LLC
NDC code
0472-1629-16
Origin
NC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-006-2013 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Phenylephrine recalls

See all

Other recalls by Actavis Mid Atlantic LLC

All 2012 recalls
Class III · Low risk

Prometh VC Plain

Impurities/Degradation Products: Recalled lots do not meet room temperature stability specification for unknown degradant.

Terminated Impurity / degradation Actavis Mid Atlantic LLC NDC 0472-1628-16 D-005-2013